Avicanna Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes

Avicanna Inc., a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that its subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH”), has completed its first export of purified cannabidiol (“CBD”) from Colombia to Canada for research and development purposes.

“We are thrilled to complete our first export and proud to be doing so into Canada,” said Aras Azadian, Chief Executive Officer of Avicanna commented, “This is another validation of Avicanna’s ability to execute on all of its verticals and demonstrates the success and advantage of Avicanna’s cultivation infrastructure, extraction and purification capacity, and regulatory expertise.”

Health Canada issued three authorizations to SMGH on June 28, 2019 to allow for the import of CBD isolates and cannabis resin into Canada from Colombia for scientific purposes. The CBD isolates cleared Colombian border procedures and were exported from Colombia on August 22, 2019.

Avicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.